DataSet Record GDS807: Expression Profiles Data Analysis Tools Sample Subsets
Title: Estrogen positive breast cancer recurrence during tamoxifen therapy: microdissected tumor
Cluster AnalysisGDS807 Cluster Image
Summary: Expression profiling of microdissected estrogen positive primary breast cancer tumors from 60 patients. Patients later treated with tamoxifen for 5 years, and tumors grouped according to whether cancer recurred. Results identify markers of disease-free survival that include HOXB13 and IL17BR.
Organism: Homo sapiens
Platform: GPL1223: Arcturus 22k human oligonucleotide microarray
  • Ma XJ, Wang Z, Ryan PD, Isakoff SJ et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004 Jun;5(6):607-16. PMID: 15193263
  • Loi S, Haibe-Kains B, Desmedt C, Wirapati P et al. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics 2008 May 22;9:239. PMID: 18498629
Reference Series: GSE1378 Sample count: 60
Value type: log ratio Series published: 2004/06/07